Fundz

Aptar Pharma acquires Pulmotree for growth

PRIVATEOct 26, 2026

Acquiring Company

Aptar Pharma

Acquired Company

Pulmotree

Crystal LakeBiotechnologyPharmaceuticalBiotechnologyHealth Care

Description

Aptar Pharma has acquired Pulmotree to expand its growth opportunities in the pulmonary drug delivery market. This acquisition will enhance Aptar's portfolio of innovative drug delivery systems.

Who to call at Aptar Pharma, and when

When Aptar Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Aptar Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aptar Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aptar Pharma. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aptar Pharma

Location

Crystal Lake, Illinois, United States

About

Aptar Pharma is a global leader in drug delivery and active material science solutions and services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aptar Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Amit
Senior decision-maker at this company
••••••••@••••••••

See Amit's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aptar Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired Pulmotree?

Pulmotree was acquired by Aptar Pharma, based in Crystal Lake. The deal was reported on October 26, 2026. Aptar Pharma is a global leader in drug delivery and active material science solutions and services. Aptar Pharma is privately held and operates in Biotechnology.

When did Aptar Pharma acquire Pulmotree?

Aptar Pharma's acquisition of Pulmotree was reported on October 26, 2026. Aptar Pharma has acquired Pulmotree to expand its growth opportunities in the pulmonary drug delivery market. This acquisition will enhance Aptar's portfolio of innovative drug delivery systems. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Pulmotree do?

Pulmotree focuses on developing next-generation pulmonary drug delivery technologies and solutions. Their innovations aim to enhance the effectiveness and convenience of respiratory medications. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.